Trinity Partners has appointed Kevin Francis to director of analytics & insights, and Alex Chiang will serve as principal. Both employees have experienced continued growth with the firm, with a tenure of almost twelve and ten years respectively.
In his new role, Kevin will be responsible for leading a team of analytics professionals that focus on leveraging secondary data to drive actionable insights for pharmaceutical and biotechnology clients. He will continue leading the firm’s charge on large-scale data integration engagements involving patient claims and transactional sales data. Kevin will also partner with the strategy consulting team to integrate secondary data into their projects.
Kevin graduated from Bentley University with an Economics degree. He has contributed analyses for several publications, including the Journal of Medical Economics and the Journal of Clinical Epidemiology. Kevin’s work has also been presented at conferences and events, including the Academy of Managed Care Pharmacy Annual Meeting, the ASH Annual Meeting and the ISPOR Annual Meeting. He has been with Trinity for more than eleven years and most recently served as engagement manager, advanced analytics.
“Kevin possesses a deep understanding of secondary data, and has leveraged that knowledge to drive actionable insights for clients.” said Dave Fitzhenry, managing partner, Trinity Partners. “Further, as he has transitioned into a leadership role, he has developed innovative processes to help refine Trinity’s data management and analytics capabilities. Not only do clients clamor to work with him, colleagues rely on Kevin and his team for quick turnaround help on important projects.”
Alex, who has been with Trinity since 2007, will continue advising life sciences clients on a range of therapeutic areas, including oncology and specialty diseases. He has had significant exposure across Trinity’s strategic offerings and practice areas, including forecasting, advanced analytics, corporate strategy, and primary market research. Alex will also continue to lead Trinity’s New York City office.
Alex received an Economics degree and a certificate in American Studies from Princeton University and an MBA from Columbia. His analysis on personalized medicine in oncology was published in Nature Reviews Drug Discovery.
“Alex is a natural leader and mentor to many Trinity employees. Accordingly, he quickly rose through the ranks from associate to engagement manager and now principal,” said Fitzhenry. “Alex has also demonstrated a knack for partnering with clients to help them maximize current assets and develop a roadmap to success across therapeutic areas.”
These promotions are an indication of Trinity’s ongoing growth. Based just outside of Boston, the company has additional offices in San Francisco, Princeton and New York City. Throughout Trinity’s twenty plus years in business, the company has prioritized investments in employee growth and development with management programs, career skills training and mentorship programs.
Just as Kevin and Alex took advantage of the career growth opportunities offered to them throughout their lengthy careers with the firm, they now serve as mentors to junior staff, and will continue to take on employee development roles in addition to their regular responsibilities.